Unique Aspects of OOS Investigations Related to Biotech Products Complimentary Learning Level: Intermediate Session Length: 1.5 hour Investigating Out of Specification (OOS) test results is crucial to ensure pharmaceutical...
Learning Level: Intermediate -
The SARS-CoV-2 worldwide pandemic has presented a significant challenge to business continuity for pharmaceutical manufacturing. It has led to Industry re-assessing the virus control framework, and in particular, any challenges that this may present to the mitigations currently in place. This presentation will focus on the SARS-CoV-2 situation and factors to be assessed in a GMP Biopharmaceutical manufacturing facility and whether they present a secure virus mitigation strategy to protect the product from contamination from this and other viruses.
- The factors involved in the virus control framework for a Biopharmaceutical manufacturing facility with reference to ICH Q5A.
- The planning activities required in order to prepare for a novel virus challenge to manufacturing facilities.
- Ongoing virus risk management and mitigations.
Speaker
Subscribe to your ISPE YouTube Channel
& Click the bell for notifications.
& Click the bell for notifications.
Past Webinars
Demystifying Machine Learning: Regression Models, Classification Models, and the AI Landscape Complimentary Learning Level: Basic Session Length: 1 hour In this webinar, Jerome Zuercher will cover basic topics of Machine...
Future of Analytical Procedures – ICH Q2(R2) & Q14: Development, Validation, & Lifecycle Management Complimentary Learning Level: Intermediate Session Length: 1.5 hour The ICH guidelines, Q2(R2) – Validation of Analytical...